View Financial HealthJiangsu Liba Enterprise 배당 및 자사주 매입배당 기준 점검 3/6Jiangsu Liba Enterprise 은(는) 현재 수익률이 6.76% 인 배당금 지급 회사입니다.핵심 정보6.8%배당 수익률0.5%자사주 매입 수익률총 주주 수익률7.3%미래 배당 수익률n/a배당 성장률21.7%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향169%최근 배당 및 자사주 매입 업데이트공시 • Oct 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces an Equity Buyback for CNY 50 million worth of its shares.Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 15 per share. The repurchased shares will be used for equity incentives plan. The program will be valid for 6 months.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥14.88, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 30% over the past three years.New Risk • Apr 28New major risk - Revenue and earnings growthEarnings have declined by 4.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 169% Cash payout ratio: 140% Earnings have declined by 4.8% per year over the past 5 years.New Risk • Apr 20New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 159% Cash payout ratio: 105% Dividend yield: 7.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.공시 • Apr 20Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 11, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 11, 2026, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu China공시 • Mar 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2025 Results on Apr 18, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2025 results on Apr 18, 2026Reported Earnings • Oct 28Third quarter 2025 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.16 (up from CN¥0.13 in 3Q 2024). Revenue: CN¥413.2m (flat on 3Q 2024). Net income: CN¥41.8m (up 22% from 3Q 2024). Profit margin: 10% (up from 8.4% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025Reported Earnings • Aug 28Second quarter 2025 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.16 (down from CN¥0.17 in 2Q 2024). Revenue: CN¥398.7m (down 6.1% from 2Q 2024). Net income: CN¥41.7m (down 6.3% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has remained flat, which means it is well ahead of earnings.공시 • Jun 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025New Risk • Apr 22New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 167% Cash payout ratio: 272% Dividend yield: 8.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 167% Cash payout ratio: 272% Minor Risk Profit margins are more than 30% lower than last year (9.3% net profit margin).Reported Earnings • Apr 19Full year 2024 earnings released: EPS: CN¥0.60 (vs CN¥2.40 in FY 2023)Full year 2024 results: EPS: CN¥0.60 (down from CN¥2.40 in FY 2023). Revenue: CN¥1.71b (up 12% from FY 2023). Net income: CN¥159.0m (down 75% from FY 2023). Profit margin: 9.3% (down from 42% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.공시 • Apr 18Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 08, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 08, 2025, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu China공시 • Mar 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025분석 기사 • Jan 10Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) Looks Inexpensive After Falling 25% But Perhaps Not Attractive EnoughJiangsu Liba Enterprise Joint-Stock Co., Ltd. ( SHSE:603519 ) shares have had a horrible month, losing 25% after a...공시 • Dec 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025Valuation Update With 7 Day Price Move • Dec 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.18, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 36x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.분석 기사 • Nov 04Jiangsu Liba Enterprise's (SHSE:603519) Shareholders Have More To Worry About Than Only Soft EarningsDespite Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) recent earnings report having lackluster...Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.20 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.20 loss in 3Q 2023). Revenue: CN¥410.0m (up 1.9% from 3Q 2023). Net income: CN¥34.2m (up CN¥87.4m from 3Q 2023). Profit margin: 8.4% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥12.52, the stock trades at a trailing P/E ratio of 69x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years.공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024분석 기사 • Sep 25Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s (SHSE:603519) Share Price Could Signal Some RiskThere wouldn't be many who think Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) price-to-sales (or...New Risk • Sep 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin).New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥1.60 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (down from CN¥1.60 in 2Q 2023). Revenue: CN¥424.5m (up 9.6% from 2Q 2023). Net income: CN¥44.5m (down 90% from 2Q 2023). Profit margin: 11% (down from 110% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.23, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 1.6% over the past three years.공시 • Jun 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2024 Results on Aug 26, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2024 results on Aug 26, 2024분석 기사 • May 06Jiangsu Liba Enterprise's (SHSE:603519) Weak Earnings May Only Reveal A Part Of The Whole PictureJiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) recent weak earnings report didn't cause a big stock...공시 • Apr 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 21, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 21, 2024, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu ChinaReported Earnings • Apr 26Full year 2023 earnings released: EPS: CN¥2.40 (vs CN¥2.12 in FY 2022)Full year 2023 results: EPS: CN¥2.40 (up from CN¥2.12 in FY 2022). Revenue: CN¥1.52b (up 7.6% from FY 2022). Net income: CN¥639.8m (up 13% from FY 2022). Profit margin: 42% (up from 40% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.공시 • Mar 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024공시 • Dec 29Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024Board Change • Dec 21Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Zhi Yi is the most experienced director on the board, commencing their role in 2020. Independent Director Xiaodong Wang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.공시 • Oct 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces an Equity Buyback for CNY 50 million worth of its shares.Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 15 per share. The repurchased shares will be used for equity incentives plan. The program will be valid for 6 months.Reported Earnings • Oct 18Third quarter 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.69 profit in 3Q 2022)Third quarter 2023 results: CN¥0.20 loss per share (down from CN¥0.69 profit in 3Q 2022). Revenue: CN¥402.4m (up 18% from 3Q 2022). Net loss: CN¥53.2m (down 129% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2023 Results on Oct 18, 2023Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2023 results on Oct 18, 2023공시 • Jun 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q2, 2023 Results on Aug 18, 2023Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q2, 2023 results on Aug 18, 2023Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥15.97, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years.Reported Earnings • Apr 26Full year 2022 earnings released: EPS: CN¥2.12 (vs CN¥0.41 in FY 2021)Full year 2022 results: EPS: CN¥2.12 (up from CN¥0.41 in FY 2021). Revenue: CN¥1.42b (down 11% from FY 2021). Net income: CN¥564.6m (up 414% from FY 2021). Profit margin: 40% (up from 6.9% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Dec 21Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥14.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.7% over the last 3 years. Earnings per share has grown by 47%.Buying Opportunity • Nov 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be CN¥15.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.7% over the last 3 years. Earnings per share has grown by 47%.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 18Third quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.081 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.081 in 3Q 2021). Revenue: CN¥339.8m (down 17% from 3Q 2021). Net income: CN¥184.7m (up CN¥161.9m from 3Q 2021). Profit margin: 54% (up from 5.6% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 22Second quarter 2022 earnings released: EPS: CN¥1.04 (vs CN¥0.072 in 2Q 2021)Second quarter 2022 results: EPS: CN¥1.04 (up from CN¥0.072 in 2Q 2021). Revenue: CN¥363.5m (up 1.8% from 2Q 2021). Net income: CN¥280.1m (up CN¥262.4m from 2Q 2021). Profit margin: 77% (up from 5.0% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jul 23Second quarter 2022 earnings released: EPS: CN¥1.04 (vs CN¥0.072 in 2Q 2021)Second quarter 2022 results: EPS: CN¥1.04 (up from CN¥0.072 in 2Q 2021). Revenue: CN¥363.5m (up 1.8% from 2Q 2021). Net income: CN¥280.1m (up CN¥262.4m from 2Q 2021). Profit margin: 77% (up from 5.0% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.11 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥407.9m (up 18% from 3Q 2020). Net income: CN¥22.9m (down 20% from 3Q 2020). Profit margin: 5.6% (down from 8.2% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.Reported Earnings • Aug 25Second quarter 2021 earnings released: EPS CN¥0.072 (vs CN¥0.092 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥357.1m (up 34% from 2Q 2020). Net income: CN¥17.7m (down 30% from 2Q 2020). Profit margin: 5.0% (down from 9.5% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥15.49, the stock trades at a trailing P/E ratio of 40.2x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 144% over the past three years.Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.43 (vs CN¥0.60 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.30b (up 1.1% from FY 2019). Net income: CN¥95.6m (down 28% from FY 2019). Profit margin: 7.4% (down from 10% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 7% per year.Is New 90 Day High Low • Mar 03New 90-day high: CN¥16.42The company is up 3.0% from its price of CN¥15.89 on 03 December 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 28New 90-day low: CN¥13.16The company is down 2.0% from its price of CN¥13.45 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Nov 27New 90-day high: CN¥17.62The company is up 31% from its price of CN¥13.48 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 30New 90-day high: CN¥15.10The company is up 8.0% from its price of CN¥13.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥99.4m, down 31% from the prior year. Total revenue was CN¥1.21b over the last 12 months, down 9.4% from the prior year.공시 • Oct 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2020 results on Oct 29, 2020공시 • Jul 17Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 603519 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: 603519 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Jiangsu Liba Enterprise 배당 수익률 vs 시장603519의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (603519)6.8%시장 하위 25% (CN)0.4%시장 상위 25% (CN)2.1%업계 평균 (Chemicals)1.2%분석가 예측 (603519) (최대 3년)n/a주목할만한 배당금: 603519 의 배당금( 6.76% )은 CN 시장에서 배당금 지급자의 하위 25%( 0.37% )보다 높습니다.고배당: 603519 의 배당금( 6.76% )은 CN 시장( 2.14% )주주 대상 이익 배당수익 보장: 지급 비율 ( 169.4% )이 높기 때문에 603519 의 배당금 지급은 수익으로 잘 충당되지 않습니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 140% )이 높기 때문에 603519 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/21 10:36종가2026/06/18 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Jiangsu Liba Enterprise Joint-Stock Co., Ltd.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Li Cong ZhangHuatai ResearchXin ZhangZhongtai Securities Co. Ltd.
공시 • Oct 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces an Equity Buyback for CNY 50 million worth of its shares.Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 15 per share. The repurchased shares will be used for equity incentives plan. The program will be valid for 6 months.
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥14.88, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 30% over the past three years.
New Risk • Apr 28New major risk - Revenue and earnings growthEarnings have declined by 4.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 169% Cash payout ratio: 140% Earnings have declined by 4.8% per year over the past 5 years.
New Risk • Apr 20New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 159% Cash payout ratio: 105% Dividend yield: 7.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
공시 • Apr 20Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 11, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 11, 2026, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu China
공시 • Mar 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2025 Results on Apr 18, 2026Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2025 results on Apr 18, 2026
Reported Earnings • Oct 28Third quarter 2025 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.16 (up from CN¥0.13 in 3Q 2024). Revenue: CN¥413.2m (flat on 3Q 2024). Net income: CN¥41.8m (up 22% from 3Q 2024). Profit margin: 10% (up from 8.4% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
Reported Earnings • Aug 28Second quarter 2025 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.16 (down from CN¥0.17 in 2Q 2024). Revenue: CN¥398.7m (down 6.1% from 2Q 2024). Net income: CN¥41.7m (down 6.3% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
공시 • Jun 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
New Risk • Apr 22New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 167% Cash payout ratio: 272% Dividend yield: 8.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 167% Cash payout ratio: 272% Minor Risk Profit margins are more than 30% lower than last year (9.3% net profit margin).
Reported Earnings • Apr 19Full year 2024 earnings released: EPS: CN¥0.60 (vs CN¥2.40 in FY 2023)Full year 2024 results: EPS: CN¥0.60 (down from CN¥2.40 in FY 2023). Revenue: CN¥1.71b (up 12% from FY 2023). Net income: CN¥159.0m (down 75% from FY 2023). Profit margin: 9.3% (down from 42% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
공시 • Apr 18Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 08, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 08, 2025, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu China
공시 • Mar 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025
분석 기사 • Jan 10Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) Looks Inexpensive After Falling 25% But Perhaps Not Attractive EnoughJiangsu Liba Enterprise Joint-Stock Co., Ltd. ( SHSE:603519 ) shares have had a horrible month, losing 25% after a...
공시 • Dec 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025
Valuation Update With 7 Day Price Move • Dec 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.18, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 36x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.
분석 기사 • Nov 04Jiangsu Liba Enterprise's (SHSE:603519) Shareholders Have More To Worry About Than Only Soft EarningsDespite Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) recent earnings report having lackluster...
Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.20 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.20 loss in 3Q 2023). Revenue: CN¥410.0m (up 1.9% from 3Q 2023). Net income: CN¥34.2m (up CN¥87.4m from 3Q 2023). Profit margin: 8.4% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥12.52, the stock trades at a trailing P/E ratio of 69x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years.
공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
분석 기사 • Sep 25Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s (SHSE:603519) Share Price Could Signal Some RiskThere wouldn't be many who think Jiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) price-to-sales (or...
New Risk • Sep 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin).
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥1.60 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (down from CN¥1.60 in 2Q 2023). Revenue: CN¥424.5m (up 9.6% from 2Q 2023). Net income: CN¥44.5m (down 90% from 2Q 2023). Profit margin: 11% (down from 110% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.23, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 1.6% over the past three years.
공시 • Jun 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2024 Results on Aug 26, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2024 results on Aug 26, 2024
분석 기사 • May 06Jiangsu Liba Enterprise's (SHSE:603519) Weak Earnings May Only Reveal A Part Of The Whole PictureJiangsu Liba Enterprise Joint-Stock Co., Ltd.'s ( SHSE:603519 ) recent weak earnings report didn't cause a big stock...
공시 • Apr 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 21, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd., Annual General Meeting, May 21, 2024, at 13:30 China Standard Time. Location: 3F, No. 88, Huaxi Road, Environmental Protection Technology Industrial Park, Yixing, Jiangsu China
Reported Earnings • Apr 26Full year 2023 earnings released: EPS: CN¥2.40 (vs CN¥2.12 in FY 2022)Full year 2023 results: EPS: CN¥2.40 (up from CN¥2.12 in FY 2022). Revenue: CN¥1.52b (up 7.6% from FY 2022). Net income: CN¥639.8m (up 13% from FY 2022). Profit margin: 42% (up from 40% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
공시 • Mar 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024
공시 • Dec 29Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024
Board Change • Dec 21Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Zhi Yi is the most experienced director on the board, commencing their role in 2020. Independent Director Xiaodong Wang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
공시 • Oct 26Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces an Equity Buyback for CNY 50 million worth of its shares.Jiangsu Liba Enterprise Joint-Stock Co., Ltd. (SHSE:603519) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 15 per share. The repurchased shares will be used for equity incentives plan. The program will be valid for 6 months.
Reported Earnings • Oct 18Third quarter 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.69 profit in 3Q 2022)Third quarter 2023 results: CN¥0.20 loss per share (down from CN¥0.69 profit in 3Q 2022). Revenue: CN¥402.4m (up 18% from 3Q 2022). Net loss: CN¥53.2m (down 129% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Sep 30Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2023 Results on Oct 18, 2023Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2023 results on Oct 18, 2023
공시 • Jun 28Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q2, 2023 Results on Aug 18, 2023Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q2, 2023 results on Aug 18, 2023
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥15.97, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years.
Reported Earnings • Apr 26Full year 2022 earnings released: EPS: CN¥2.12 (vs CN¥0.41 in FY 2021)Full year 2022 results: EPS: CN¥2.12 (up from CN¥0.41 in FY 2021). Revenue: CN¥1.42b (down 11% from FY 2021). Net income: CN¥564.6m (up 414% from FY 2021). Profit margin: 40% (up from 6.9% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Dec 21Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥14.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.7% over the last 3 years. Earnings per share has grown by 47%.
Buying Opportunity • Nov 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be CN¥15.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.7% over the last 3 years. Earnings per share has grown by 47%.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 18Third quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.081 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.081 in 3Q 2021). Revenue: CN¥339.8m (down 17% from 3Q 2021). Net income: CN¥184.7m (up CN¥161.9m from 3Q 2021). Profit margin: 54% (up from 5.6% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 22Second quarter 2022 earnings released: EPS: CN¥1.04 (vs CN¥0.072 in 2Q 2021)Second quarter 2022 results: EPS: CN¥1.04 (up from CN¥0.072 in 2Q 2021). Revenue: CN¥363.5m (up 1.8% from 2Q 2021). Net income: CN¥280.1m (up CN¥262.4m from 2Q 2021). Profit margin: 77% (up from 5.0% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jul 23Second quarter 2022 earnings released: EPS: CN¥1.04 (vs CN¥0.072 in 2Q 2021)Second quarter 2022 results: EPS: CN¥1.04 (up from CN¥0.072 in 2Q 2021). Revenue: CN¥363.5m (up 1.8% from 2Q 2021). Net income: CN¥280.1m (up CN¥262.4m from 2Q 2021). Profit margin: 77% (up from 5.0% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.11 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥407.9m (up 18% from 3Q 2020). Net income: CN¥22.9m (down 20% from 3Q 2020). Profit margin: 5.6% (down from 8.2% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 25Second quarter 2021 earnings released: EPS CN¥0.072 (vs CN¥0.092 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥357.1m (up 34% from 2Q 2020). Net income: CN¥17.7m (down 30% from 2Q 2020). Profit margin: 5.0% (down from 9.5% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥15.49, the stock trades at a trailing P/E ratio of 40.2x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 144% over the past three years.
Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.43 (vs CN¥0.60 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.30b (up 1.1% from FY 2019). Net income: CN¥95.6m (down 28% from FY 2019). Profit margin: 7.4% (down from 10% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 7% per year.
Is New 90 Day High Low • Mar 03New 90-day high: CN¥16.42The company is up 3.0% from its price of CN¥15.89 on 03 December 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 28New 90-day low: CN¥13.16The company is down 2.0% from its price of CN¥13.45 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Nov 27New 90-day high: CN¥17.62The company is up 31% from its price of CN¥13.48 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 30New 90-day high: CN¥15.10The company is up 8.0% from its price of CN¥13.92 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥99.4m, down 31% from the prior year. Total revenue was CN¥1.21b over the last 12 months, down 9.4% from the prior year.
공시 • Oct 27Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report Q3, 2020 results on Oct 29, 2020
공시 • Jul 17Jiangsu Liba Enterprise Joint-Stock Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020Jiangsu Liba Enterprise Joint-Stock Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020